MX2018010536A - Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales. - Google Patents

Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.

Info

Publication number
MX2018010536A
MX2018010536A MX2018010536A MX2018010536A MX2018010536A MX 2018010536 A MX2018010536 A MX 2018010536A MX 2018010536 A MX2018010536 A MX 2018010536A MX 2018010536 A MX2018010536 A MX 2018010536A MX 2018010536 A MX2018010536 A MX 2018010536A
Authority
MX
Mexico
Prior art keywords
disease
detection
methods
compositions
diagnosis
Prior art date
Application number
MX2018010536A
Other languages
English (en)
Inventor
V S N Yerramilli Murthy
Farace Giosi
Yerramilli Mahalakshmi
Joseph Quinn John
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of MX2018010536A publication Critical patent/MX2018010536A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/18—Dental and oral disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/348—Urinary tract infections
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)

Abstract

La descripción proporciona composiciones y métodos para la detección de enfermedades renales y enfermedades periodontales en mamíferos.
MX2018010536A 2016-03-02 2017-03-02 Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales. MX2018010536A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662302299P 2016-03-02 2016-03-02
PCT/US2017/020377 WO2017151871A1 (en) 2016-03-02 2017-03-02 Methods and compositions for the detection and diagnosis of renal disease and periodontal disease

Publications (1)

Publication Number Publication Date
MX2018010536A true MX2018010536A (es) 2018-11-09

Family

ID=58410448

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018010536A MX2018010536A (es) 2016-03-02 2017-03-02 Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.

Country Status (15)

Country Link
US (2) US10725052B2 (es)
EP (2) EP4299586A3 (es)
JP (3) JP7187317B2 (es)
KR (2) KR102424496B1 (es)
CN (1) CN108700600B (es)
AR (1) AR107786A1 (es)
AU (1) AU2017225758B2 (es)
BR (1) BR112018067292A2 (es)
CA (1) CA3016163A1 (es)
DK (1) DK3423838T3 (es)
MX (1) MX2018010536A (es)
NZ (1) NZ745263A (es)
TW (1) TWI822655B (es)
WO (1) WO2017151871A1 (es)
ZA (1) ZA201806418B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019032746A1 (en) 2017-08-08 2019-02-14 Fresenius Medical Care Holdings, Inc. SYSTEMS AND METHODS FOR TREATING AND ESTIMATING THE PROGRESSION OF CHRONIC RENAL DISEASE
JP7207585B2 (ja) * 2017-09-01 2023-01-18 株式会社三洋物産 遊技機
CN110938130B (zh) * 2019-11-08 2021-07-09 上海交通大学 一种生物活性多肽rvfqplphenkpltl及其制备方法和应用
US11175293B1 (en) 2021-01-04 2021-11-16 University Of Utah Research Foundation Rapid assay for detection of SARS-CoV-2 antibodies
JP2021079146A (ja) * 2021-02-22 2021-05-27 株式会社三洋物産 遊技機
JP7315071B2 (ja) * 2021-03-03 2023-07-26 株式会社三洋物産 遊技機

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
NL1020962C2 (nl) 2002-06-28 2003-12-30 Tno Therapie en prognose/monitoring bij sepsis en septische shock.
CA2533803A1 (en) 2003-07-29 2005-02-10 Bristol-Myers Squibb Company Biomarkers of cyclin-dependent kinase modulation
US20070087448A1 (en) 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use
CA2595377A1 (en) * 2005-01-28 2006-08-03 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
US8383357B2 (en) 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
JP2009502112A (ja) 2005-07-28 2009-01-29 オンコセラピー・サイエンス株式会社 腎細胞癌を診断および処置するための方法
WO2008021290A2 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
CN101120904B (zh) 2006-11-13 2011-06-29 李复生 癌症疾病治疗器
EP2535718B1 (en) 2007-05-11 2014-07-09 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
US20090075266A1 (en) * 2007-09-14 2009-03-19 Predictive Biosciences Corporation Multiple analyte diagnostic readout
EP2679238A1 (en) * 2008-10-02 2014-01-01 Celtaxsys, INC. Methods of modulating the negative chemotaxis of immune cells
US20110287964A1 (en) 2008-11-17 2011-11-24 The Brigham And Women's Hospital, Inc. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
US9476868B2 (en) * 2009-12-23 2016-10-25 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
KR101222437B1 (ko) * 2010-03-17 2013-01-15 경북대학교 산학협력단 바이오마커
JP5855094B2 (ja) * 2010-06-03 2016-02-09 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． 腎疾患のためのマーカー
CN101937000A (zh) * 2010-08-05 2011-01-05 北京倍爱康生物技术有限公司 一种人胱抑素c的磁微粒分离化学发光免疫分析检测方法

Also Published As

Publication number Publication date
JP2019508694A (ja) 2019-03-28
NZ745263A (en) 2022-07-01
ZA201806418B (en) 2019-07-31
KR102424496B1 (ko) 2022-07-25
KR20180114936A (ko) 2018-10-19
EP4299586A2 (en) 2024-01-03
KR20210127763A (ko) 2021-10-22
JP2022028790A (ja) 2022-02-16
US20170269101A1 (en) 2017-09-21
WO2017151871A1 (en) 2017-09-08
EP3423838B1 (en) 2023-11-08
TW201736850A (zh) 2017-10-16
AR107786A1 (es) 2018-06-06
AU2017225758B2 (en) 2023-03-16
CN108700600A (zh) 2018-10-23
AU2017225758A1 (en) 2018-08-30
KR102311590B1 (ko) 2021-10-12
BR112018067292A2 (pt) 2019-01-02
DK3423838T3 (da) 2024-02-05
CA3016163A1 (en) 2017-09-08
JP7187317B2 (ja) 2022-12-12
US20200400683A1 (en) 2020-12-24
CN108700600B (zh) 2022-06-03
EP4299586A3 (en) 2024-04-03
EP3423838A1 (en) 2019-01-09
US10725052B2 (en) 2020-07-28
JP2024028816A (ja) 2024-03-05
TWI822655B (zh) 2023-11-21

Similar Documents

Publication Publication Date Title
MY191169A (en) Anti-fcrh5 antibodies
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MD3240554T2 (ro) Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
MX2018010536A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
PH12016501763A1 (en) Multispecific antibodies
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MD3307288T2 (ro) Compoziții care conțin tulpini bacteriene
MD3360559T2 (ro) Compoziții conținând tulpini bacteriene
MD3204024T2 (ro) Compoziții care conțin tulpini bacteriene
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
SG10201803042PA (en) Anti-tim-3 antibodies
EA201790545A1 (ru) Антитела и иммуноконъюгаты против her2
MX2017000419A (es) Anticuerpos anti-pd-l1 y sus usos de diagnóstico.
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
TWD172538S (zh) 電動牙刷之部分
MY193650A (en) Extracellular matrix compositions
SG10201808278TA (en) Polishing composition and polishing method
EP3151733A4 (en) Compositions and methods for characterizing and diagnosing periodontal disease
MX2016005473A (es) Metodos y composiciones para mejorar la funcion renal.
MX2018000708A (es) Composiciones y metodos para desgomar aceite.
MA39355A1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants